In vitroneurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses
- 1 February 2010
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 121 (2), 120-126
- https://doi.org/10.1111/j.1600-0404.2009.01200.x
Abstract
To determine glutamate and aspartate levels in the cerebrospinal fluid (CSF) in patients with sporadic amyotrophic lateral sclerosis (SALS) grouped according to El Escorial diagnostic criteria, and to perform an in vitro assessment of the neurotoxicity of the CSF in murine cortical neurons. SALS patients were sorted according to El Escorial diagnostic criteria. Glutamate and aspartate were measured in the CSF using high performance liquid chromatography. Cultured cortical neuron viability was determined after exposure to CSF for 24 h. Glutamate levels were elevated in 28 out of the 29 patients with definite, probable or possible SALS. There were no differences in glutamate concentrations when the three clinical forms of the disease were compared; neither there were significant variation across disease duration and clinical presentation. In agreement with previous reports, we concluded that CSF-SALS-induced in vitro neurotoxicity is mediated by ionotropic glutamate receptors. We found no relationship between the degree of in vitro neurotoxicity and glutamate concentration in the CSF. Glutamate but not aspartate CSF levels may contribute to ALS pathogenesis. However, glutamate levels may not influence the degree of diagnosis certainty or lesion extension.This publication has 28 references indexed in Scilit:
- Let all DNA voteNeurology, 2008
- Targets in ALS: designing multidrug therapiesTrends in Pharmacological Sciences, 2006
- Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like diseaseJournal of Neuroscience Research, 2005
- A mutation in dynein rescues axonal transport defects and extends the life span of ALS miceThe Journal of cell biology, 2005
- Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in miceHuman Molecular Genetics, 2003
- Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosisAnnals of Neurology, 1995
- Excitatory amino acids in amyotrophic lateral sclerosisAnnals of Neurology, 1991
- Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluidAnnals of Neurology, 1990
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosisAnnals of Neurology, 1988